Corvia Medical

Corvia Medical

Private
Tewksbury, MassachusettsHealthcare & Life Scienceshttps://www.corviamedical.com

Last Round

Series D

Jun 17, 2025

Total Funding Raised

$152.11M

Company Overview

Corvia is a medical device company that develops a transcatheter device aimed at alleviating symptoms and slowing the progression of heart failure by creating a small opening between the left and right atria to lower blood pressure in the left atrium and lungs.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

atrial shuntheart shuntheart failure treatmenttranscatheter deviceHFpEFcardiac implantdiastolic heart failureHFmrEFleft atrial pressure reductioninterventional cardiologyminimally invasive implantMedTechcardiovascular deviceFDA Breakthrough Deviceinvestigational device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Corvia Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Corvia Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJun 17, 2025
VC RoundJun 9, 2022
StrategicMar 11, 2019
Series DJul 1, 2014
Series AMar 19, 2013
Series B
May 13, 2011

Key People

Founding team and executive leadership

George Fazio

President CEO

Executive Team

Corvia Medical Investors

Notable investors and investment history

InvestorRounds
General CatalystVC Round, Series B, Series D, Series A, Strategic
Lumira VenturesSeries D, Strategic, VC Round, Series A
AccelmedSeries D, Strategic, VC Round
Third Rock VenturesSeries B, Series A, Series D, Strategic, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 31, 2025

    Developing an implantable device for heart failure patients.

Corvia Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Corvia Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Corvia Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersTewksbury, Massachusetts
Employee Range40
Year Founded2009
Last FundingJun 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.